Vanguard Group’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

Vanguard Group’s Portfolio SVNT Stock Details SVNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-3,337,281	Closed	-$2.08M	–	3951
2013 Q3	$2.08M	Buy	3,337,281 +156,503	+5%	+$100K	﹤0.01%	3116
2013 Q2	$1.78M	Buy	+3,180,778	New	+$2.22M	﹤0.01%	3110

Other funds holding SVNT

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

FHC

First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return

PSC

Prentiss Smith & Co Brattleboro, Vermont $182M AUM 26.44% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Vanguard Group's SVNT Position: Q4 2013 in Review

Vanguard Group sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q4 2013, closing a stake of 3,337,281 shares — an estimated $2.08M sold.

Vanguard Group first reported a position in SVNT in Q2 2013 and held it in 2 quarters. The position peaked at $2.08M in Q3 2013. 7 funds tracked by Wall St. Rank hold SVNT as of Q4 2013.

Vanguard Group reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
Vanguard Group sold 3,337,281 SAVIENT PHARMACEUTICALS INC shares in Q4 2013, an estimated $2.08M.
Vanguard Group first reported a position in SAVIENT PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
Vanguard Group's SAVIENT PHARMACEUTICALS INC position peaked at $2.08M in Q3 2013.
7 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q4 2013.

Based on Vanguard Group's 13F filing for Q4 2013, filed 12 Feb 2014.